StockData
Immuron Ltd logo

Immuron Ltd (IMRN) stock

IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 24, 2026Score 4/30
$0.87−0.00 (-0.52%)

Close on Nov 18, 2026Market cap $6.99MP/E –Yield –

Immuron net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2026 it was -A$3.68M. The highest annual figure on record is -A$2.85M in fiscal 2022.

Annual net income

PeriodPeriod endValueChange
FY2026Jun 30, 2026-A$3.68M–
FY2025Jun 30, 2025-A$5.22M–
FY2024Jun 30, 2024-A$6.94M–
FY2023Jun 30, 2023-A$3.79M–
FY2022Jun 30, 2022-A$2.85M–
FY2021Jun 30, 2021-A$8.38M–
FY2020Jun 30, 2020-A$2.93M–
FY2019Jun 30, 2019-A$4.66M–

More Immuron figures

See a number that looks wrong?